Valuation Shanghai Shyndec Pharmaceutical Co., Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 2026-02-13			5-day change	1st Jan Change
10.63 ^CNY	-1.12%		-1.57%	+5.25%

Feb. 12	Shyndec Pharmaceutical Secures Bids For 51 Drugs in China's Latest Procurement Program	MT
Feb. 09	Shyndec Pharmaceutical's Subsidiary Passes GMP Inspection	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024
Capitalization ¹	9,181	9,766	10,650	9,346	13,130	16,014
Change	-	6.38%	9.04%	-12.25%	40.5%	21.96%
Enterprise Value (EV) ¹	8,687	9,853	10,550	6,601	8,302	9,508
Change	-	13.42%	7.07%	-37.43%	25.77%	14.53%
P/E ratio	15.7x	17.3x	21.5x	16.8x	18x	14.8x
PBR	1.21x	1.2x	1.24x	1.06x	1.06x	1.21x
PEG	-	-4.96x	-1.7x	1.3x	244.31x	0.3x
Capitalization / Revenue	0.75x	0.78x	0.76x	0.72x	1.09x	1.46x
EV / Revenue	0.71x	0.78x	0.76x	0.51x	0.69x	0.87x
EV / EBITDA	4.67x	5.42x	5.7x	3.96x	4.7x	4.16x
EV / EBIT	7.63x	9x	9.79x	7.85x	8.58x	6.19x
EV / FCF	-26.2x	-97.5x	17x	4.04x	4.62x	5.7x
FCF Yield	-3.82%	-1.03%	5.89%	24.7%	21.6%	17.5%
Dividend per Share ²	0.1	0.1	0.1	0.1	0.1	0.3
Rate of return	1.12%	1.05%	0.96%	1.1%	1.02%	2.51%
EPS ²	0.57	0.5501	0.4825	0.5429	0.5433	0.808
Distribution rate	17.5%	18.2%	20.7%	18.4%	18.4%	37.1%
Net sales ¹	12,199	12,556	13,945	12,959	12,070	10,938
EBITDA ¹	1,858	1,818	1,851	1,665	1,766	2,288
EBIT ¹	1,138	1,095	1,078	841.2	967.3	1,536
Net income ¹	656.4	648.8	568.3	627.8	691.9	1,084
Net Debt ¹	-493.4	86.79	-99.84	-2,745	-4,828	-6,505
Reference price ²	8.94	9.51	10.37	9.10	9.79	11.94
Nbr of stocks (in thousands)	1,026,937	1,026,958	1,026,964	1,026,983	1,341,173	1,341,173
Announcement Date	4/1/20	3/25/21	3/25/22	3/29/23	3/29/24	3/27/25

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	-	-	-	-	2.06B
MERCK KGAA	19.38x	2.99x	10.32x	1.83%	65.31B
HALOZYME THERAPEUTICS, INC.	14.28x	7.33x	11.46x	-	9.46B
KYOWA KIRIN CO., LTD.	24.81x	2.38x	10.38x	2.3%	8.87B
SK BIOPHARMACEUTICALS CO., LTD.	48.87x	11.62x	36.61x	-.--%	5.92B
YUHAN CORPORATION	67.06x	3.59x	41.47x	0.46%	5.59B
INDIVIOR PHARMACEUTICALS, INC.	19.74x	3.69x	10.58x	-.--%	4.34B
SUPERNUS PHARMACEUTICALS, INC.	-72.96x	-	-	-	2.96B
BETTA PHARMACEUTICALS CO., LTD.	33.8x	5.76x	18.98x	0.79%	2.79B
Average	19.37x	5.33x	19.97x	0.9%	11.92B
Weighted average by Cap.	21.37x	3.97x	13.90x	1.56%